With endless gratitude and excitement for the next chapter
Today we announced new leadership at Calibrate
Before Ozempic was a household name, the earliest Calibraters gathered around a single table in New York City and defined Calibrate’s mission to change the way the world treats weight, drafted our vision to put consumers back in control of their health, and aligned on our values: real results matter, in it together, small wins create big wins, and you’re in control. Over the last four years, we have used these principles to build products that have changed tens of thousands of lives with unparalleled real results.
That same earliest team also set the strategy for building an entirely new category: We developed our program and proved that it worked, and we used those proof points to make Calibrate available and accessible through partnerships with national payors and employers who use our programs to deliver value-based care in what we knew would become the largest category of healthcare spend ever seen.
We started Calibrate with the belief that we all deserve a new chronic disease treatment paradigm—that medication is a tool, not a long-term treatment. I believe we have a once-in-a-generation opportunity to harness the public’s excitement about GLP-1s into the catalyst for a fundamentally better healthcare system that cost-effectively delivers personalized, holistic care combining medicine, coaching, content, and community.
This fall, we agreed as a Board that Calibrate can best execute on the massive opportunity ahead with a new capitalization structure, and we decided to sell Calibrate to one of our largest investors, Madryn Capital. As part of that transaction, I am stepping down from my role as CEO at Calibrate. I am endlessly proud of what I have been able to accomplish over the last four years and am forever grateful to each Calibrater who challenged me, stretched me, and enabled me to grow in this role. I will always evangelize our mission, vision, and values as our founder.
I am also honored to share that we have promoted two Leadership Team members to oversee our day-to-day operations: Ed Cudahy to President & Chief Operating Officer and Scott Honken to President & Chief Commercial Officer. Over the last two years, I have been inspired by Ed & Scott’s commitment to our members, our team, and our partners. But most importantly, I’ve been inspired by how they each lead: relentlessly raising the bar for the spectacular things we achieve when we embody our values to support each other’s best work.
Building Calibrate has been the most indelible experience of my career, and I am grateful to each of the members, team members, investors, and partners that supported me at every step.
In the last four years, we’ve brought Calibrate to just 0.3% of Americans. We’re changing the way the world treats weight, and we’re just getting started.
